Dehydroepiandrosterone sulfate (DHEAS) is the sulfated form of dehydroepiandrosterone and stands as the most abundant steroid hormone in human circulation. Secreted by the adrenal cortex as a weak androgen, it serves as a crucial precursor for the biosynthesis of both estrogens and androgens. DHEAS is a key biomarker for diagnosing adrenal pathologies—such as adrenal tumors, adrenal insufficiency, and congenital adrenal hyperplasia—and is also utilized in the differential diagnosis of Cushing's syndrome.

AccuSift provides high-performance competitive antibody pairs for DHEAS detection. These reagents offer exceptional inter-batch consistency and are optimized specifically for IVD kit development, including lateral flow assays, chemiluminescence, ELISA, and POCT platforms. Featuring high affinity and high specificity, they enable rapid and reliable detection.

Sensitivity: ELISA LOD: 0.8 ng/mL